“It was announced with great fanfare that universal health had returned to spain, but it is not true”
Home Slider
“It was announced with great fanfare that universal health had returned to spain, but it is not true”
28/02/2019 by in Home Slider
The State is the largest invester in Health R&D, but does not guarantee the social return of that investment
Home Slider
The State is the largest invester in Health R&D, but does not guarantee the social return of that investment
31/01/2019 by in Home Slider
“I’m going to get to a point where I’m told that there is no more treatment that the NHS can offer me”
Home Slider
“I’m going to get to a point where I’m told that there is no more treatment that the NHS can offer me”
18/01/2019 by in Home Slider
“There is no guarantee that the next treatments for cancer will not come with even higher prices”
Home Slider
“There is no guarantee that the next treatments for cancer will not come with even higher prices”
20/12/2018 by in Home Slider
We are still in the legal battle against the patent for the hepatitis C drug
Home Slider
We are still in the legal battle against the patent for the hepatitis C drug
10/12/2018 by in Home Slider
We organized the meeting ‘The fight against HIV and tuberculosis: progress and challenges’
Home Slider
We organized the meeting ‘The fight against HIV and tuberculosis: progress and challenges’
16/11/2018 by in Home Slider
We travel to the High Level Meeting on Non-Communicable Diseases
Home Slider
We travel to the High Level Meeting on Non-Communicable Diseases
16/11/2018 by in Home Slider
Tuberculosis: what remains to be done
Home Slider
Tuberculosis: what remains to be done
16/11/2018 by in Home Slider
Disappointment: the European Patent Office maintains the sofosbuvir patent
Home Slider
Disappointment: the European Patent Office maintains the sofosbuvir patent
16/11/2018 by in Home Slider
We ask, together with other civil society organizations, the end of Gilead’s unjustified monopoly in Europe on the anti-hepatitis C drug
Home Slider
We ask, together with other civil society organizations, the end of Gilead’s unjustified monopoly in Europe on the anti-hepatitis C drug
16/11/2018 by in Home Slider